REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/29/2025
Back to search
Official data from USPTO
VIROCURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
12/30/2025
Trademark type
Combined
Nice classes
40, 42
Filing date
04/19/2019
Registration date
12/29/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/29/2020
Last transaction
12/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
03
Owner location
Guro-Gu Seoul, KR
Examiner
HERRERA-MARCUS,ROSELLE MORALDE
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the literal element "ViroCure" in stylized font with "VIRO" in orange and "CURE" in blue, to the right of a design element of a double helix in blue, outlined in white with an orange center with blue stripes all within a blue hexagon border.
Holders and representatives
Holders
VIROCURE, INC.
Representatives
Ryan D. Artis RIVERSIDE LAW LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of biopharmaceuticals; treatment of biopharmaceutical materials; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; processing of medical products; chemical treatment of liquids; preservation of pharmaceuticals; custom manufacture of medical devices for others; processing of blending agents for the manufacture of biopharmaceuticals; processing and handling of chemical reagents; processing of chemicals
Class 42
Medicine research; research for medical products; veterinary laboratory services; research and development of vaccines and medicines; pharmaceutical products development; research of pharmaceuticals; pharmaceutical research and development; pharmaceutical research services; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; clinical studies of medicines for research purposes; clinical testing of medicines for research purposes; pharmaceutical drug development services; testing/inspection or research of pharmaceuticals/cosmetics or foodstuff; development of biotechnology; research in the field of pharmacogenetics; biochemical research and development; scientific research for medical purposes in the field of cancerous diseases; conducting clinical trials for others for scientific research
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/29/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/13/2020
PUBO
PUBLISHED FOR OPPOSITION
10/13/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/23/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/12/2020
GNRT
NON-FINAL ACTION E-MAILED
02/12/2020
CNRT
NON-FINAL ACTION WRITTEN
02/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2020
ALIE
ASSIGNED TO LIE
02/10/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/05/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/09/2020
GNSL
LETTER OF SUSPENSION E-MAILED
01/09/2020
CNSL
SUSPENSION LETTER WRITTEN
01/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/07/2019
GNRT
NON-FINAL ACTION E-MAILED
07/07/2019
CNRT
NON-FINAL ACTION WRITTEN
07/07/2019
DOCK
ASSIGNED TO EXAMINER
06/28/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2019
NWAP
NEW APPLICATION ENTERED
04/23/2019
Continuous trademark protection
Get notified about every new filing that threatens VIROCURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.